DrugCard
AI-powered pharmacovigilance automation for global and local literature monitoring and regulatory intelligence
DrugCard is an AI-powered platform that automates literature screening and pharmacovigilance processes for pharmaceutical companies and CROs, covering 151+
About the business
DrugCard is an AI-powered pharmacovigilance platform that automates literature screening and drug safety monitoring across global and local medical journals. The platform covers 151+ countries and monitors 2300+ local journals in 100+ languages, enabling pharmaceutical companies and CROs to achieve 50-70% time savings compared to manual screening while capturing more relevant information.
The platform combines automated article analysis, regulatory intelligence tracking, and adverse event management with professional pharmacovigilance services including case processing, signal detection, and periodic safety documentation. DrugCard serves MAHs, CROs, and freelancers by automating routine screening tasks so pharmacovigilance specialists can focus on higher-value activities like signal detection and risk assessment.
Founded in 2019 by brothers Artem and Dmytro Horilyk with CTO Myroslav Demchun, DrugCard has grown to serve 48 clients across 55 countries. The company combines proprietary OCR technology with AI models trained on real pharmacovigilance data to deliver 99% accuracy in text recognition and automated article categorization for drug safety monitoring.
What you get
- Automated literature monitoring across 100+ languages
- Coverage of 151+ countries and 2300+ local medical journals
- OCR technology with 99% accuracy for scanned texts
- Regulatory intelligence tracking
- Adverse event database and case management
- AI Case Intake module for automated data extraction
- PSUR and PBRER automation
- Weekly and instant email notifications
- Signal detection capabilities
- Integration with safety database for auto-population
Neighbours ask
Can DrugCard screen medical literature in local languages?
Yes, screening medical literature in local languages is DrugCard's main competitive strength. The platform successfully reads 100+ languages and has covered 2300+ local journals, allowing users to search with keywords in Greek, Hindi, Arabic, Japanese and many others.
Can DrugCard recognize poorly scanned texts?
Yes, DrugCard uses proprietary OCR technology that delivers up to 99% accuracy even for average quality scanned texts, enabling screening of printed hard copies of journals with imperfect scan quality.
How long does it take to add journals in a new country?
On average, it takes 2-3 weeks to add journals in a new country, depending on the specific country and number of journals. In some cases, DrugCard has managed to add 100 custom journals for a client in just one month.
What are DrugCard's unique strengths compared to competition?
DrugCard's main competitive strengths include discovering 3-5 times more hits than manual approaches, achieving 50-70% time savings on screening, and delivering 99% accuracy in keyword recognition of average scanned texts. The company views manual literature screening processes and unwillingness to change as their primary competition.
Leave a review for DrugCard
No one has reviewed DrugCard yet. Say something first. Reviews are free. A business can't pay for them.
DrugCard has a free listing. The owner can unlock the full profile with a paid launch for $5:
- Founder story (locked)
- Milestones (locked)
- Demo video (locked)
- Dofollow website link (locked)
Also opened nearby
NumenHealth tech
Reverse Age LabHealth tech
CoSys WorkHealth tech
MurphHealth tech